Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting

نویسندگان

  • S Bonora
  • A Calcagno
  • O Viganò
  • P Bigliano
  • S Rusconi
  • L Trentini
  • MC Tettoni
  • G Orofino
  • B Salassa
  • C Bramato
  • A D'Avolio
  • M Siccardi
  • E Colella
  • M Galli
  • G Di Perri
چکیده

Materials and methods A retrospective analysis of virological (responder = last viral load < 50 copies/ml) and PK data of patients (pts) administered with ATV 400 mg QD + 2 N(Nt)RTIs for at least 3 months was performed. Genotypic Sensitivity Score (GSS) and ATV resistance associated mutations (RAMs) were calculated according to Stanford database using cumulative genotype. ATV Ctrough was measured by a validated HPLC method.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study

Data on the long-term efficacy and safety of abacavir/lamivudine (ABC/3TC) and nevirapine (NVP) are scarce. This combination has the advantage of simplifying treatment and improving long-term tolerance. The aim of this study was to compare the rate of any discontinuation of antiretroviral (ARV) regimen because of virologic failure (VF), and/or adverse drug reaction (ADR) among patients receivin...

متن کامل

Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study

BACKGROUND Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. METHODS AND RESULTS This multicenter retrospective cohort study evaluated the efficacy of switching HIV-1-infected patients controlled on trip...

متن کامل

Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patients.

Limited data on the pharmacokinetics and pharmacodynamics (PK/PD) of unboosted atazanavir (uATV) in treatment-experienced patients are available. The aim of this work was to study the PK/PD of unboosted atazanavir in a cohort of HIV-infected patients. Data were available for 58 HIV-infected patients (69 uATV-based regimens). Atazanavir concentrations were analyzed by using a population approach...

متن کامل

Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients

Purpose of the study Atazanavir (ATV)-based regimens have demonstrated efficacy and safety in both ARV-naïve and -experienced patients. However, few reports have assessed effectiveness beyond 2 years. The aim of this study was to describe the long-term outcomes of ATV/r containing regimens in ARV-experienced patients in a clinical setting. Methods Non-comparative, retrospective, observational s...

متن کامل

Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens

BACKGROUND Antiretrovirals used to treat HIV-infected patients have the potential to adversely affect serum lipid profiles and increase the risk of cardiovascular disease which is an emerging concern among HIV-infected patients. Since boosted atazanavir and efavirenz are both considered preferred antiretrovirals a head to head comparison of their effects on serum lipids is needed. AIM The pri...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 13  شماره 

صفحات  -

تاریخ انتشار 2010